Limitations, agreements, and source contact

Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer · Source last updated 2019-07-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

LTE60

restrictive Agreement

true

point Of Contact

email

kurasa@nrgoncology.org

organization

NRG Oncology Statistics and Data Management Center - Buffalo

phone

716-845-7733

title

Angela M. Kuras, Associate Director of Data Management

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice